Cargando…

Adult attention-deficit/hyperactivity disorder is associated with reduced norepinephrine transporter availability in right attention networks: a (S,S)-O-[(11)C]methylreboxetine positron emission tomography study

The norepinephrine transporter (NET) has been suggested to play a critical role in attention-deficit/hyperactivity disorder (ADHD). In this prospective controlled study we tested the a-priori-hypothesis that central NET availability is altered in adult ADHD patients compared to healthy controls. Stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ulke, Christine, Rullmann, Michael, Huang, Jue, Luthardt, Julia, Becker, Georg-Alexander, Patt, Marianne, Meyer, Philipp M., Tiepolt, Solveig, Hesse, Swen, Sabri, Osama, Strauß, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858438/ https://www.ncbi.nlm.nih.gov/pubmed/31732713 http://dx.doi.org/10.1038/s41398-019-0619-y

Ejemplares similares

Association between Individual Norepinephrine Transporter (NET) Availability and Response to Pharmacological Therapy in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD)
por: Huang, Jue, et al.
Publicado: (2022)

Increased pulmonary serotonin transporter in patients with chronic obstructive pulmonary disease who developed pulmonary hypertension
por: Frille, Armin, et al.
Publicado: (2020)

Higher HbA1c levels associate with lower hippocampal serotonin transporter availability in non-diabetic adults with obesity
por: Grundmann, Rico, et al.
Publicado: (2020)

HPA Axis Responsiveness Associates with Central Serotonin Transporter Availability in Human Obesity and Non-Obesity Controls
por: Schinke, Christian, et al.
Publicado: (2022)

Current radiotracers to image neurodegenerative diseases
por: Tiepolt, Solveig, et al.
Publicado: (2019)

Brain arousal regulation and depressive symptomatology in adults with attention-deficit/hyperactivity disorder (ADHD)
por: Huang, Jue, et al.
Publicado: (2019)

Availability of Central α4β2* Nicotinic Acetylcholine Receptors in Human Obesity
por: Schweickert de Palma, Eva, et al.
Publicado: (2022)

Changes of central noradrenaline transporter availability in immunotherapy-naïve multiple sclerosis patients
por: Schmidt, Elisa, et al.
Publicado: (2020)

Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer’s dementia
por: Sabri, Osama, et al.
Publicado: (2018)

Involvement of Norepinephrine in the Control of Activity and Attentive Processes in Animal Models of Attention Deficit Hyperactivity Disorder
por: Viggiano, D., et al.
Publicado: (2004)

(+)-[(18)F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand—results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer’s disease and healthy controls
por: Tiepolt, Solveig, et al.
Publicado: (2020)

Central Serotonin/Noradrenaline Transporter Availability and Treatment Success in Patients with Obesity
por: Griebsch, Nora-Isabell, et al.
Publicado: (2022)

Central Noradrenergic Neurotransmission and Weight Loss 6 Months After Gastric Bypass Surgery in Patients with Severe Obesity
por: Soeder, J. Marvin, et al.
Publicado: (2021)

Suppressed Fat Appetite after Roux-en-Y Gastric Bypass Surgery Associates with Reduced Brain μ-opioid Receptor Availability in Diet-Induced Obese Male Rats
por: Hankir, Mohammed K., et al.
Publicado: (2017)

Feasibility of in vivo (18)F-florbetaben PET/MR imaging of human carotid amyloid-β
por: Bucerius, Jan, et al.
Publicado: (2017)

Gender differences in adult ADHD: Cognitive function assessed by the test of attentional performance
por: Stibbe, Tina, et al.
Publicado: (2020)

Possible association of norepinephrine transporter -3081(A/T) polymorphism with methylphenidate response in attention deficit hyperactivity disorder
por: Kim, Boong-Nyun, et al.
Publicado: (2010)

Multicenter (18)F-PI-2620 PET for In Vivo Braak Staging of Tau Pathology in Alzheimer’s Disease
por: Rullmann, Michael, et al.
Publicado: (2022)

Serotonin transporter gene promoter methylation status correlates with in vivo prefrontal 5-HTT availability and reward function in human obesity
por: Drabe, M, et al.
Publicado: (2017)

Exploring the Metabolism of (+)-[(18)F]Flubatine In Vitro and In Vivo: LC-MS/MS Aided Identification of Radiometabolites in a Clinical PET Study †
por: Ludwig, Friedrich-Alexander, et al.
Publicado: (2018)

Possible effect of norepinephrine transporter polymorphisms on methylphenidate-induced changes in neuropsychological function in attention-deficit hyperactivity disorder
por: Park, Subin, et al.
Publicado: (2012)

No Evidence for Association Between Norepinephrine Transporter-3081 (A/T) Polymorphism and Attention Deficit Hyperactivity Disorder in Iranian Population
por: Eslami Amirabadi, Mohammad Reza, et al.
Publicado: (2015)

Pharmacokinetics of Ampreloxetine, a Norepinephrine Reuptake Inhibitor, in Healthy Subjects and Adults with Attention-Deficit/Hyperactive Disorder or Fibromyalgia Pain
por: Kanodia, Jitendra, et al.
Publicado: (2020)

Norepinephrine influences the circadian clock in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder
por: Palm, Denise, et al.
Publicado: (2021)

Functional specificity of the locus coeruleus-norepinephrine system in the attentional networks
por: Ambrosini, Ettore, et al.
Publicado: (2013)

Training of attention functions in children with attention deficit hyperactivity disorder
por: Tucha, Oliver, et al.
Publicado: (2011)

Connectivity supporting attention in children with attention deficit hyperactivity disorder
por: Barber, Anita D., et al.
Publicado: (2014)

Attention Patterns in Children with Attention Deficit Disorder with or without Hyperactivity
por: Zalsman, Gil, et al.
Publicado: (2003)

Neurophysiological Correlates of Attentional Fluctuation in Attention-Deficit/Hyperactivity Disorder
por: Cheung, Celeste H. M., et al.
Publicado: (2017)

Autistic Trait, Empathy, and Attention-Deficit/Hyperactivity Symptoms in Women with Idiopathic Hirsutism
por: Bilgiç, Ayhan, et al.
Publicado: (2015)

The 1287 G/A polymorphism of the Norepinephrine Transporter gene (NET) is involved in Commission Errors in Korean children with Attention Deficit Hyperactivity Disorder
por: Song, Dong-Ho, et al.
Publicado: (2011)

Pupil Size Tracks Attentional Performance In Attention-Deficit/Hyperactivity Disorder
por: Wainstein, G., et al.
Publicado: (2017)

Thoracic [18F]fluorodeoxyglucose uptake measured by positron emission tomography/computed tomography in pulmonary hypertension
por: Frille, Armin, et al.
Publicado: (2016)

In vitro and in vivo Human Metabolism of (S)-[(18)F]Fluspidine – A Radioligand for Imaging σ(1) Receptors With Positron Emission Tomography (PET)
por: Ludwig, Friedrich-Alexander, et al.
Publicado: (2019)

Management of attention-deficit hyperactivity disorder
por: Verma, Rohit, et al.
Publicado: (2011)

The history of attention deficit hyperactivity disorder
por: Lange, Klaus W., et al.
Publicado: (2010)

Stigma in attention deficit hyperactivity disorder
por: Mueller, Anna K., et al.
Publicado: (2012)

Attention Deficit Hyperactivity Disorder and Athletes
por: White, Russell D., et al.
Publicado: (2014)

Driving and attention deficit hyperactivity disorder
por: Fuermaier, Anselm B. M., et al.
Publicado: (2015)

Genetics of attention deficit hyperactivity disorder
por: Faraone, Stephen V., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_oo73l80humbkqnt929op474icc